GALECTIN THERAPEUTICS INC (GALT) Share-based Payment Arrangement, Expense USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Galectin Therapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • Galectin Therapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $604 K, a 8.76% decline year-over-year.
  • Galectin Therapeutics Inc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $2.2 M, a 17.5% decline year-over-year.
  • Galectin Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2023 was $2.26 M, a 21.1% decline from 2022.
  • Galectin Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2022 was $2.87 M, a 38.1% increase from 2021.
  • Galectin Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2021 was $2.08 M, a 15.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.2 M $604 K -$58 K -8.76% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.26 M $497 K -$184 K -27% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $2.45 M $586 K -$95 K -14% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.54 M $516 K -$131 K -20.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.67 M $662 K -$196 K -22.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $2.87 M $681 K +$27 K +4.13% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $2.84 M $681 K +$94 K +16% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $2.75 M $647 K +$66 K +11.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.68 M $858 K +$604 K +238% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $2.08 M $654 K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $587 K +$179 K +43.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $581 K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $254 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $408 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.